Plain-English translation of NCT06422455 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new tool called PERLA—an AI chatbot that teaches patients about genetic testing before they meet with a genetic counselor. Genetic testing can identify whether certain cancers run in families and help guide treatment decisions. The study wants to see if PERLA makes it easier and faster for cancer patients, especially those in underserved communities, to get genetic testing and understand their results.
Many cancer patients who could benefit from genetic testing never receive it, especially if they face barriers like language differences or limited access to genetic counseling. This trial aims to solve that problem by using technology to provide education that is available anytime, in multiple languages, and tailored to each patient's needs.
You likely qualify if…
You likely don't qualify if…
Depending on the phase, you may attend focus groups to share feedback on the chatbot, complete usability testing to try out the tool, or be randomly assigned to either use PERLA (the new AI chatbot plus standard genetic counseling) or receive usual genetic counseling. The sessions take 20 to 60 minutes, and you'll be followed up at 1, 3, and 6 months after completing the intervention to see how the tool worked for you.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States